Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+15.72%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$832M
Cap. Flow %
-7.27%
Top 10 Hldgs %
38.52%
Holding
1,212
New
71
Increased
449
Reduced
354
Closed
26

Sector Composition

1 Real Estate 74.35%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.66%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IRWD icon
1001
Ironwood Pharmaceuticals
IRWD
$184M
$11K ﹤0.01%
1,174
+281
+31% +$2.63K
XNCR icon
1002
Xencor
XNCR
$600M
$11K ﹤0.01%
358
+98
+38% +$3.01K
BOLD
1003
DELISTED
Audentes Therapeutics, Inc
BOLD
$11K ﹤0.01%
271
+106
+64% +$4.3K
OPK icon
1004
Opko Health
OPK
$1.13B
$10K ﹤0.01%
3,729
+638
+21% +$1.71K
PCRX icon
1005
Pacira BioSciences
PCRX
$1.2B
$10K ﹤0.01%
262
+38
+17% +$1.45K
TCDA
1006
DELISTED
Tricida, Inc. Common Stock
TCDA
$10K ﹤0.01%
268
-71
-21% -$2.65K
AIMT
1007
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$9K ﹤0.01%
395
+114
+41% +$2.6K
MNTA
1008
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9K ﹤0.01%
626
+204
+48% +$2.93K
FL
1009
DELISTED
Foot Locker
FL
$9K ﹤0.01%
152
GLOB icon
1010
Globant
GLOB
$2.71B
$9K ﹤0.01%
125
-375
-75% -$27K
OMAB icon
1011
Grupo Aeroportuario Centro Norte
OMAB
$5.14B
$9K ﹤0.01%
200
PBYI icon
1012
Puma Biotechnology
PBYI
$230M
$9K ﹤0.01%
243
+36
+17% +$1.33K
RUBY
1013
DELISTED
Rubius Therapeutics, Inc
RUBY
$9K ﹤0.01%
503
-134
-21% -$2.4K
DBC icon
1014
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
$8K ﹤0.01%
500
INVA icon
1015
Innoviva
INVA
$1.29B
$8K ﹤0.01%
597
TBPH icon
1016
Theravance Biopharma
TBPH
$701M
$8K ﹤0.01%
+353
New +$8K
WNS icon
1017
WNS Holdings
WNS
$3.24B
$8K ﹤0.01%
+150
New +$8K
WVE icon
1018
Wave Life Sciences
WVE
$1.21B
$8K ﹤0.01%
213
-24
-10% -$901
SPPI
1019
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$8K ﹤0.01%
706
+150
+27% +$1.7K
CLVS
1020
DELISTED
Clovis Oncology, Inc.
CLVS
$8K ﹤0.01%
336
+65
+24% +$1.55K
APLS icon
1021
Apellis Pharmaceuticals
APLS
$3.4B
$7K ﹤0.01%
358
-142
-28% -$2.78K
EDIT icon
1022
Editas Medicine
EDIT
$251M
$7K ﹤0.01%
304
+71
+30% +$1.64K
ESPR icon
1023
Esperion Therapeutics
ESPR
$506M
$7K ﹤0.01%
171
+26
+18% +$1.06K
FATE icon
1024
Fate Therapeutics
FATE
$111M
$7K ﹤0.01%
410
-140
-25% -$2.39K
GLPG icon
1025
Galapagos
GLPG
$2.21B
$7K ﹤0.01%
60